Features, Symptoms, and Neurophysiological Findings in Stroke Associated With Hyperhomocysteinemia
- 1 October 1997
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 54 (10) , 1276-1282
- https://doi.org/10.1001/archneur.1997.00550220074017
Abstract
Background: Hyperhomocysteinemia has been shown to be a mild independent risk factor for premature atherosclerosis, and there is evidence of an increased rate of peripheral vascular occlusive disease, myocardial infarction, and stroke. Objective: To evaluate clinical, biochemical, and neurophysiological findings in patients with ischemic stroke with and without hyperhomocysteinemia. Subjects: One hundred twenty-five consecutive patients with a history of stroke and 60 healthy control subjects. Methods: Patients were divided into those with and those without hyperhomocysteinemia, which was defined as blood levels beyond the mean total plasma homocysteine level plus 2 SDs of the healthy control group. History, symptoms, cause, patterns of infarction, biochemical data, continuous and transcranial Doppler sonography, and event-related potentials were recorded in all patients. Results: Twenty-seven patients had hyperhomocysteinemia. Compared with the 98 patients without hyperhomocysteinemia, they had an increased rate of hypertension (odds ratio, 3.5; 95% confidence interval, 1.0-12.6), an increased level of uric acid (P<.007), an increased hematocrit (P<.02), a higher rate of microangiopathy (odds ratio, 2.8; 95% confidence interval, 1.1-7.2), and a trend to a higher rate of multiple infarction. Furthermore, the P3 latency of the event-related potential was significantly increased in hyperhomocysteinemia (P<.004). Conclusions: Hyperhomocysteinemia is probably an independent risk factor for stroke, with a prevalence of about 20% in all patients with a history of stroke; however, additional factors (eg, hypertension, hyperuricemia) may have an enhancing effect. There are significant differences in stroke patterns between patients with and without hyperhomocysteinemia, with a higher rate of lesions typical of cerebral microangiopathy and a trend to multiple infarctions in the former. Impairment of cognitive processing as measured by visual event-related potential is more pronounced in hyperhomocysteinemia.Keywords
This publication has 10 references indexed in Scilit:
- Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging StudyThe American Journal of Clinical Nutrition, 1996
- Homocysteine and coronary atherosclerosisJournal of the American College of Cardiology, 1996
- Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British menThe Lancet, 1995
- Serum Folate and Risk for Ischemic StrokeStroke, 1995
- Plasma Homocysteine in the Acute and Convalescent Phases After StrokeStroke, 1995
- A prospective study of plasma homocyst(e)ine and risk of ischemic stroke.Stroke, 1994
- Functional and morphological deficits in late-treated patients with homocystinuria: a clinical, electrophysiologic and MRI studyActa Neurologica Scandinavica, 1991
- Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke.Stroke, 1990
- Plasma sulfhydryl-containing amino acids in patients with cerebral infarction and in hypertensive subjectsAtherosclerosis, 1989
- Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1987